Cipher Pharmaceuticals Inc. (FRA:PHE)

Cipher Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	7.49	17.84	39.83	28.84	20.55
Cash & Short-Term Investments	7.49	17.84	39.83	28.84	20.55
Cash Growth	-57.99%	-55.21%	38.11%	40.34%	124.76%
Accounts Receivable	11.21	13.86	5.09	6.8	6.66
Inventory	8.19	5.79	2.98	2.15	1.65
Other Current Assets	1.16	1	0.38	0.37	0.47
Total Current Assets	28.05	38.48	48.27	38.16	29.33
Net Property, Plant & Equipment	0.57	0.68	0.4	0.48	0.5
Other Intangible Assets	72.01	78.75	1.76	2.75	3.65
Goodwill	17.45	17.45	15.71	15.71	15.71
Other Long-Term Assets	38.43	27.15	19.89	16.67	2.47
Total Assets	156.5	162.51	86.03	73.78	51.65
Accounts Payable	6.39	5.87	4.6	4.11	5.56
Current Portion of Leases	0.29	0.28	0.09	0.1	0.06
Unearned Revenue	18.35	13.31	0.56	0.26	0.45
Other Current Liabilities	0.01	0.41	-	4.9	6.23
Total Current Liabilities	25.04	19.87	5.25	9.37	12.29
Long-Term Debt	5	40	-	-	-
Long-Term Leases	0.22	0.3	0.26	0.33	0.46
Total Long-Term Liabilities	5.22	40.3	0.26	0.33	0.46
Total Liabilities	30.26	60.17	5.51	9.7	12.75
Common Stock	27.86	27.68	18.01	17.72	18.12
Additional Paid-in Capital	7.79	6.53	5.76	5.36	5.09
Accumulated Other Comprehensive Income	-9.51	-9.51	-9.51	-9.51	-9.51
Retained Earnings	100.11	77.65	66.27	50.52	25.2
Shareholders' Equity	126.24	102.34	80.52	64.08	38.9
Total Liabilities & Equity	156.5	162.51	86.03	73.78	51.65
Total Debt	5.51	40.58	0.35	0.43	0.52
Net Cash (Debt)	1.99	-22.74	39.47	28.41	20.03
Net Cash Growth	-	-	38.95%	41.81%	174.67%
Net Cash Per Share	-	-0.90	1.55	0.00	0.75
Book Value	126.24	102.34	80.52	64.08	38.9
Book Value Per Share	-	4.06	3.17	0.00	1.45
Tangible Book Value	36.78	6.14	63.05	45.62	19.54
Tangible Book Value Per Share	-	0.24	2.48	0.00	0.73

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.